Roche VENTANA MMR test wins EU IVDR approval
Used as a predictive biomarker, the first-of-its-kind VENTANA MMR RxDx Panel helps identify cancer patients eligible for treatment…
Top pharmaceutical companies for innovation: Roche, AbbVie, Novartis, and more
The 2020 Pharmaceutical Invention and Innovation Indices, compiled by IDEA Pharma, were generated prior to the unfolding COVID-19…
Better Pharma Dividend Stock: Novartis vs. Merck
The pharmaceutical industry is a good place to look for solid dividend stocks. Since they offer lifesaving therapies,…
Better Pharma Dividend Stock: Novartis vs. Merck
Key Points Merck’s outlook is bright despite challenges to its core franchises. Novartis is performing well despite a…
Merck to buy Terns for $6.7B, taking a leukemia drug that could challenge Novartis’ Scemblix
Merck is looking to further solidify its oncology pipeline via a $6.7 billion cash acquisition of Terns Pharmaceuticals…